MELISSA LAMIRAND: Open Payments
NPI 1346706371 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,628 in 26 payments from 2 companies in 2025. Trend: 2023 $23,049 · 2024 $22,056 · 2025 $22,628
Speaker / faculty: $16,151Travel & lodging: $5,090Food & beverage: $737Consulting: $650
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 25 | $21,978 |
| GlaxoSmithKline, LLC. | 1 | $650 |
Products named: SARCLISA.
Industry payments across NC — which companies pay providers there.
